This product is a chimeric (mouse/human) monoclonal antibody with N-glycosylation site in the Fc region. The antibody 4G3 with enhanced ADCC specifically binds renal Cell Carcinoma and can be potentially used in the treatment of renal carcinoma.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-068LC | Recombinant Anti-Human Renal Cell Carcinoma Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
Gly-069LC | Recombinant Anti-Human Renal Cell Carcinoma Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
Gly-070LC | Recombinant Anti-Human Renal Cell Carcinoma Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
Gly-071LC | Recombinant Anti-Human Renal Cell Carcinoma Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
Gly-073LC | Recombinant Anti-Human Renal Cell Carcinoma Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
There are currently no Customer reviews or questions for Gly-072LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.